| Group I & III (Non-DM) (n = 93) | Group II & IV (DM) (n = 87) | P | Group I & II (Non-CAD) (n = 84) | Group III & IV (CAD) (n = 96) | P |
Serum Thrombospondin-1 (TSP–1) (ng/mL) | 516.91 ± 64.56 | 582.95 ± 55.70 | <0.001* | 525.17 ± 61.77 | 569.54 ± 68.16 | <0.001* |